ABOUT OUR SCAFFOLD
Paretor manufactures a mineral nanoparticle colloid (MNC) scaffold that can be adapted for delivery of nucleotides, small molecules, and peptides to the cytoplasm of the cell.
​
MNCs are colloids, not a crude nanoparticle suspension, are non-magnetic, and have dextran and minerals such as magnesium and choline integrated into the particle itself.
Our technology is based on legacy iron-oxide nanoparticles that have a 30-year history of clinical use in oncology; however, Paretor MNCs have a unique set of characteristics which solve key problems that have hindered nanoparticle adoption for drug delivery and use as a research, commercial, and clinical tool in the past.
​
OUR PRODUCTS AND PARTNERSHIPS
Manufacturing and Bioprocessing
ETAERION (PA-002) is a magnesium-integrated mineral nanoparticle colloid that stabilizes cellular systems under stress. It is designed to be used in research and commercial settings to improve stability and viability of cell lines and organoid systems. Contact us to learn about wholesale supply. Order ETERION here.
RNA Delivery
Paretor nanoparticle colloid PA-001 can be used for non-disruptive RNA delivery to the cell cytoplasm and are adapted for siRNA screening. Paretor is looking for academic and industry partners who are interested in delivering RNA outside of the liver. Order Paretor particles for delivery here.
Actives Delivery
Paretor nanoparticle colloid PA-001 can also be modified with small molecules, peptides, and other cargo for delivery to the cell cytoplasm. Non-disruptive delivery into the cytoplasm paves the way for low-dose delivery, novel therapeutics, and true reformulation of existing agents.
Paretor Partnerships
Paretor is a manufacturer, not a pharmaceutical company. We work with academia, biotech founders, manufacturers, and other industry partners to develop nanoparticle colloids for non membrane- disruptive delivery of small molecules, nucleotides, peptides, and other cargo to the cell cytoplasm. We are always happy to serve our customers and drive science and medicine forward together.
WHAT MAKES PARETOR DIFFERENT
Paretor is a manufacturer, not a pharmaceutical company. Particles + novel cargo can be licensed and patented for development.
We offer product-associated services such as custom particle services and particle validation.
Particles are R & D ready and GMP-enabled.
PURCHASE
Paretor nanoparticle colloids PA-001 and ETAERION (PA-002) are available to the research community for purchase.
We offer bespoke nanoparticle colloid synthesis (RNA, small molecules, peptides, etc.) as well as validation testing. To order a custom particle, please contact us.
If you are interested in bulk ordering for ETAERION, please contact us.
Jane Cheng , M.Sc
Principal Scientist
ABOUT US
Paretor's next-generation nanoparticles-- mineral nanoparticle colloid scaffolds can be adapted for delivery of nucleotides, small molecules, and peptides to the cytoplasm of the cell.
​
​
Paretor was founded by Dustan Bonnin, MBA in 2024 as a way to democratize RNA therapeutic development and advance delivery outside the liver.
​
Our goal is to become critical infrastructure for more efficient biomanufacturing and a delivery-first resource for research and therapeutic development involving RNA delivery as well as intracellular delivery of actives.
​
​
​
Dustan Bonnin, MBA
Founder & CEO
Ginny Vachon, PhD
Chief Operations Officer
Lan Wang MD, M.Sc
Vice President, R&D
Jenna Bassett, PhD
​
Ralph Sinclair, BA
Administrative Assistant